Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk.
However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively.
Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agenda—outlining gaps in current knowledge and opportunities for providing additional insight into these issues—that summarizes and prioritizes pressing research needs.
Table of Contents |
skim chapter | |
|---|---|---|
| Front Matter | i-xviii | |
| Summary | 1-24 | |
| 1 Introduction | 25-42 | |
| 2 Cannabis | 43-60 | |
| 3 Cannabis: Prevalence of Use, Regulation, and Current Policy Landscape | 61-84 | |
| 4 Therapeutic Effects of Cannabis and Cannabinoids | 85-140 | |
| 5 Cancer | 141-160 | |
| 6 Cardiometabolic Risk | 161-180 | |
| 7 Respiratory Disease | 181-198 | |
| 8 Immunity | 199-216 | |
| 9 Injury and Death | 217-244 | |
| 10 Prenatal, Perinatal, and Neonatal Exposure to Cannabis | 245-266 | |
| 11 Psychosocial | 267-288 | |
| 12 Mental Health | 289-332 | |
| 13 Problem Cannabis Use | 333-356 | |
| 14 Cannabis Use and the Abuse of Other Substances | 357-376 | |
| 15 Challenges and Barriers in Conducting Cannabis Research | 377-394 | |
| 16 Recommendations to Support and Improve the Cannabis Research Agenda | 395-402 | |
| Appendix A Glossary | 403-408 | |
| Appendix B Study Approach | 409-442 | |
| Appendix C Systematic Reviews | 443-452 | |
| Appendix D Public Session Agendas | 453-456 | |
| Appendix E Biographical Sketches for Committee Members, Staff, Fellow, and Advisor | 457-468 | |
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Loading stats for The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research...
Finding similar items...
